Open, single-blind, double-blind: which peer review process do you prefer?

BMC Pharmacology and Toxicology was created from the merger of two journals within the BMC series published by BioMed Central: BMC Pharmacology and BMC Clinical Pharmacology. BMC Pharmacology operated anonymous peer review whereas BMC Clinical Pharmacology operated a fully open peer review policy wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Moylan, Elizabeth C, Harold, Simon, O’Neill, Ciaran, Kowalczuk, Maria K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191873/
https://www.ncbi.nlm.nih.gov/pubmed/25266119
http://dx.doi.org/10.1186/2050-6511-15-55
Descripción
Sumario:BMC Pharmacology and Toxicology was created from the merger of two journals within the BMC series published by BioMed Central: BMC Pharmacology and BMC Clinical Pharmacology. BMC Pharmacology operated anonymous peer review whereas BMC Clinical Pharmacology operated a fully open peer review policy where the identity of the reviewers was known to the editors, authors and readers. The merged journal also adopted a fully open peer review policy. Two years on we discuss the views and experiences of our Editorial Board Members towards open peer review on this biomedical journal.

Ejemplares similares